Cancer Genetic Markers of Susceptibility (CGEMS)
Contact Us  |  Site Map  |    Search  
Division of Cancer Epidemiology and Genetics Office of Cancer Genomics Core Genotyping Facility
About CGEMS News & Announcements Resource Room

 

 

National Cancer Institute U.S. National Institute of Health www.cancer.gov
Finding genetic risk factors for cancer
 
  Cancer Genetic Markers of Susceptibility Project
Cancer Genetic Markers of Susceptibility Project

The Cancer Genetic Markers of Susceptibility (CGEMS) project began in 2005 as a 3-year pilot study to identify inherited genetic susceptibility to prostate and breast cancer. CGEMS has developed into a robust research program involving genome-wide association studies (GWASs) for a number of cancers to identify common genetic variants that affect a person’s risk of developing cancer. In collaboration with extramural scientists, NCI’s Division of Cancer Epidemiology and Genetics (DCEG) has carried out genome-wide scans for breast, prostate, pancreatic, and lung cancers, while a GWAS of bladder cancer is currently underway.

Learn more >>

 
      Spotlight
Spotlight

Risk of Pancreatic Cancer Linked to Variation in Gene that Determines Blood Type
August 2, 2009
Common variants of the gene that determines human blood type are associated with an increased risk of pancreatic cancer.

View advance online publication released August 2, 2009 in Nature Genetics.

Researchers Identify Genetic Variations That May Increase Breast Cancer Risk
March 29, 2009
Study identifies new genetic variations that may be associated with risk of sporadic breast cancer and confirms some previously identified associations between specific regions in the genome and breast cancer risk.

View advance online publication released March 29, 2009 in Nature Genetics.

 

 

National Cancer InstituteDepartment of Health and Human ServicesNational Institutes of HealthFirstGov.gov